These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14646623)

  • 1. Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens.
    Lohmann CM; Hwu WJ; Iversen K; Jungbluth AA; Busam KJ
    Melanoma Res; 2003 Dec; 13(6):595-601. PubMed ID: 14646623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
    Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
    Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma or not? Cancer testis antigens may help.
    Lüftl M; Schuler G; Jungbluth AA
    Br J Dermatol; 2004 Dec; 151(6):1213-8. PubMed ID: 15606517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
    Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor antigen expression in melanoma varies according to antigen and stage.
    Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence.
    Perez D; Herrmann T; Jungbluth AA; Samartzis P; Spagnoli G; Demartines N; Clavien PA; Marino S; Seifert B; Jaeger D
    Int J Cancer; 2008 Oct; 123(7):1551-5. PubMed ID: 18646188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
    Lim E; Browning J; MacGregor D; Davis ID; Cebon JS
    Melanoma Res; 2006 Aug; 16(4):347-55. PubMed ID: 16845331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
    Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
    Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections.
    Kaufmann O; Koch S; Burghardt J; Audring H; Dietel M
    Mod Pathol; 1998 Aug; 11(8):740-6. PubMed ID: 9720502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
    Chitale DA; Jungbluth AA; Marshall DS; Leitao MM; Hedvat CV; Kolb D; Spagnoli GC; Iversen K; Soslow RA
    Mod Pathol; 2005 Jan; 18(1):119-26. PubMed ID: 15272278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
    Trefzer U; Hofmann M; Reinke S; Guo YJ; Audring H; Spagnoli G; Sterry W
    Melanoma Res; 2006 Apr; 16(2):137-45. PubMed ID: 16567969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
    Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
    Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
    Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
    Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.
    Xu X; Chu AY; Pasha TL; Elder DE; Zhang PJ
    Am J Surg Pathol; 2002 Jan; 26(1):82-7. PubMed ID: 11756773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer/testis (CT) antigens are expressed in fetal ovary.
    Nelson PT; Zhang PJ; Spagnoli GC; Tomaszewski JE; Pasha TL; Frosina D; Caballero OL; Simpson AJ; Old LJ; Jungbluth AA
    Cancer Immun; 2007 Jan; 7():1. PubMed ID: 17217256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.